POSCO Holdings Up Nearly 16%, on Pace for Largest percent Increase Since November 2008 — Data Talk
POSCO Holdings Inc. Sponsored ADR (PKX) is currently at $96.78, up $13.34 or 15.98%
--Would be highest close since Oct. 9, 2023, when it closed at $96.82
--On pace for largest percent increase since Nov. 21, 2008, when it rose 25.01%
--Currently up three consecutive days; up 26.55% over this period
--Best three day stretch since the three days ending July 25, 2023, when it rose 36.12%
--Up 77.67% year-to-date; on pace for best year since 2007, when it rose 81.94%
--Down 50.6% from its all-time closing high of $195.89 on Oct. 2, 2007
--Up 98.64% from 52 weeks ago (Nov. 7, 2022), when it closed at $48.72
--Down 26.61% from its 52-week closing high of $131.86 on July 25, 2023
--Up 98.64% from its 52-week closing low of $48.72 on Nov. 7, 2022
--Traded as high as $98.00; highest intraday level since Oct. 3, 2023, when it hit $100.58
--Up 17.45% at today's intraday high; largest intraday percent increase since July 24, 2023, when it rose as much as 18.64%
All data as of 3:10:03 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 06, 2023 15:28 ET (20:28 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year